The nation of Zimbabwe has rejected a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for sensitive information.
This move was revealed following a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official representative later explained that the US was seeking health data for research and commercial gain but was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further talks to reach a agreement agreeable to all parties so the nation's vital HIV programme can continue.
Broader Implications
Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a similar health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and accountability.
Based on reports, Sixteen African countries have to date signed these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to share its biological resources and data for a long time, without any corresponding guarantee of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the end products would be accessible to our citizens should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were undermining frameworks previously established through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage future pandemics.
"This mechanism is designed to guarantee that when a nation provides its data, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that talks must proceed given that much of the country's HIV programmes relied on foreign aid.
"If specific concerns exist, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group added.
The situation underscores the ongoing tensions between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.